Minocycline for acute stroke treatment: a systematic review and meta-analysis of randomized clinical trials

Minocycline and matrix metalloproteinase inhibition in acute intracerebral hemorrhage: a pilot study

(2017) J. J. Chang et al.   EUROPEAN JOURNAL OF NEUROLOGY

Minocycline in Acute Cerebral Hemorrhage

(2017) Abdelrahman Y. Fouda et al.   STROKE

Sequential Therapy with Minocycline and Candesartan Improves Long-Term Recovery After Experimental Stroke

(2015) Sahar Soliman et al.   Translational Stroke Research

An open-label evaluator-blinded clinical study of minocycline neuroprotection in ischemic stroke: gender-dependent effect

(2014) Mohammad Reza Amiri-Nikpour et al.   ACTA NEUROLOGICA SCANDINAVICA

Effects of Minocycline Plus Tissue Plasminogen Activator Combination Therapy After Focal Embolic Stroke in Type 1 Diabetic Rats

(2013) Xiang Fan et al.   STROKE

Association of Molecular Markers With Perihematomal Edema and Clinical Outcome in Intracerebral Hemorrhage

(2013) Na Li et al.   STROKE

Intravenous Minocycline in Acute Stroke

(2013) Edith Kohler et al.   STROKE

Efficacy of minocycline in acute ischemic stroke: A single-blinded, placebo-controlled trial

(2012) MV Padma Srivastava et al.   NEUROLOGY INDIA

Matrix Metalloproteinase-9 in an Exploratory Trial of Intravenous Minocycline for Acute Ischemic Stroke

(2011) Jeffrey A. Switzer et al.   STROKE

Minocycline to Improve Neurologic Outcome in Stroke (MINOS)

(2010) Susan C. Fagan et al.   STROKE

Minocycline and Tissue-Type Plasminogen Activator for Stroke

(2009) Livia S. Machado et al.   STROKE

Blood–Brain Barrier Disruption in Humans Is Independently Associated With Increased Matrix Metalloproteinase-9

(2009) Taura L. Barr et al.   STROKE

Extension of the Thrombolytic Time Window With Minocycline in Experimental Stroke

(2008) Yoshihiro Murata et al.   STROKE